Compare BKH & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BKH | STVN |
|---|---|---|
| Founded | 1941 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Containers/Packaging |
| Sector | Utilities | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.2B |
| IPO Year | 2001 | 2021 |
| Metric | BKH | STVN |
|---|---|---|
| Price | $72.19 | $14.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $76.33 | $25.67 |
| AVG Volume (30 Days) | ★ 830.8K | 565.5K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.98% | 0.43% |
| EPS Growth | ★ 1.79 | N/A |
| EPS | ★ 3.98 | N/A |
| Revenue | ★ $2,310,000,000.00 | N/A |
| Revenue This Year | $5.32 | $10.26 |
| Revenue Next Year | $3.82 | $10.02 |
| P/E Ratio | ★ $17.72 | $27.15 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $54.92 | $13.91 |
| 52 Week High | $75.83 | $28.00 |
| Indicator | BKH | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 47.45 | 43.56 |
| Support Level | $70.78 | $14.03 |
| Resistance Level | $73.75 | $17.14 |
| Average True Range (ATR) | 1.68 | 0.87 |
| MACD | -0.38 | 0.04 |
| Stochastic Oscillator | 46.63 | 25.11 |
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.